About Paracrine
Paracrine is a company based in San Diego (United States) founded in 2018. Paracrine offers products and services including Paracrine Cell Therapy. Paracrine operates in a competitive market with competitors including BiomX, Aurealis Therapeutics, NovaLead Pharma, CellResearch Therapeutics and Kasiak Research, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paracrine, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paracrine
Paracrine offers a comprehensive portfolio of products and services, including Paracrine Cell Therapy.
Therapy using regenerative cells for healing chronic wounds and ulcers effectively.
People of Paracrine
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Paracrine
Detailed funding history for Paracrine
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paracrine
Investment portfolio details for Paracrine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paracrine
Detailed financials for Paracrine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paracrine Comparisons
Peer comparison for Paracrine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paracrine
Paracrine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BiomX, Aurealis Therapeutics, NovaLead Pharma, CellResearch Therapeutics and Kasiak Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microbiome therapeutics are developed for dysbiosis-linked diseases.
|
|
| Locked | Locked | Locked |
Provider of cell & gene therapy platforms for chronic wounds, cancer, and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug repurposing and discovery are enabled by a proprietary platform.
|
|
| Locked | Locked | Locked |
Pioneers stem cell research for treatments of diabetic foot ulcers and hair loss conditions.
|
|
| Locked | Locked | Locked |
Develops innovative stem cell-based therapies for treating diabetic foot ulcers.
|
Detailed competitors of Paracrine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paracrine
Complete news archive for Paracrine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paracrine
Paracrine was founded in 2018.
Paracrine is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Christopher J Calhoun is the current CEO of Paracrine.
Paracrine was founded in 2018 and is based in San Diego, United States. Focus is placed on biotechnology, with operations centered on developing therapeutics for wound care. The pipeline features ASCEND, targeted at diabetic foot ulcers, and DEPICT, intended for hospital-acquired pressure injuries. Efforts are directed toward addressing unmet needs in patient treatment within this sector.
Paracrine's top competitors include BiomX, Aurealis Therapeutics and NovaLead Pharma.
Paracrine offers Paracrine Cell Therapy.